Sanford Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Sanford Health sits in the top decile of US sponsors by registered trial count (#484 of 15,742 sponsors by registered trial count).

34 total trials 6 currently recruiting 10 completed early-phase tilt top decile by trial count

Sanford Health: 34 sponsored US clinical trials, 6 recruiting.

Sanford Health sponsors 34 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 10 completed. 2 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anterior Cruciate Ligament Injuries, with 2 trials.

Top-decile sponsor footprint

Sanford Health ranks in the top decile of sponsors by registered trial count (#484 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 0/100

10 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (55.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

34 total, page 1 of 1

RECRUITING NA

Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

NCT06883266

RECRUITING

Midwest Birth Outcomes and Indigenous American Pregnancy

NCT06008561

RECRUITING

Baseline ACL Injury Risk Screening and Normative Data

NCT06635668

RECRUITING

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

NCT04477928

RECRUITING Phase 4

Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

NCT03858231

RECRUITING

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT01793168

ACTIVE NOT RECRUITING NA

Utilization of a 3D Printed Customized Knee Extender and At-Home Rehabilitation Program on Patient Outcomes Following ACL Surgery

NCT06524349

ACTIVE NOT RECRUITING

Maternal Stress and Blood Sugar Metabolization

NCT05798377

ACTIVE NOT RECRUITING NA

SH Dr. Chen Gastric Bypass Study

NCT05357443

ACTIVE NOT RECRUITING Phase 2

Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen

NCT05591547

ACTIVE NOT RECRUITING NA

A Comprehensive Approach to Head and Neck Cancer Prehabilitation

NCT04617678

ACTIVE NOT RECRUITING

EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers

NCT03777384

ACTIVE NOT RECRUITING

Cancer Stem Cells in Acute Leukemia

NCT03735797

ACTIVE NOT RECRUITING NA

Transcranial Direct Current Stimulation for Cognitive Improvement in Parkinson's Patients

NCT03191916

ACTIVE NOT RECRUITING NA

Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms

NCT02294435

NOT YET RECRUITING

Glucose Levels and Outcomes in Women - Mid Pregnancy

NCT07598149

TERMINATED NA

Playmaker 3D Printed Knee Extender

NCT05878652

TERMINATED

A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells

NCT04405297

TERMINATED Phase 3

Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection

NCT04372017

COMPLETED NA

the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer

NCT03908996

COMPLETED

Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke

NCT03618290

TERMINATED

Autoantibodies in Breast Cancer Detection

NCT03623945

COMPLETED Phase 2

Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation

NCT02889562

TERMINATED Phase 2

Investigation of Corticosteroid Versus Placebo Injection in Patients With Syndesmotic Ligament Injury or High Ankle Sprain

NCT02892500

COMPLETED Phase 1

Pembrolizumab in Combination With CRT for LA-SCCHN

NCT02586207

TERMINATED NA

Study to Evaluate the Effectiveness of Cardiac Rehabilitation (Rehab) for Acute Decompensated Heart Failure Patients on 6 Minute Walk Test and Quality of Life

NCT02179242

COMPLETED

Genetic Exploration of the Molecular Basis of Malignancy in Adults

NCT02416518

TERMINATED NA

Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates

NCT02007759

TERMINATED Phase 2

Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer

NCT02008994

COMPLETED NA

Bridging the Docosahexaenoic Acid (DHA) Gap: The Effects of Omega-3 Fatty Acid Supplementation in Premature Infants

NCT01908907

COMPLETED NA

Study of Topical Superoxide Dismutase to Treat Radiation Induced Fibrosis

NCT01771991

COMPLETED Phase 2

Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma

NCT01386632

COMPLETED

Prevalence of Human Papillomavirus in Men Living in the Northern Plains

NCT01265212

COMPLETED Phase 2

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes

NCT01155284

What is open in the Sanford Health pipeline

6 recruiting of 34 indexed (18% open); 10 completed (29%).

Phase mix: 2 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Anterior Cruciate Ligament Injuries (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Sanford Health: open-pipeline peers nationwide

Peers matched on 34 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Sanford Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1520253035 0%10%20%30%40%50% Total trials Recruiting share Sanford HealthAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)American RegentAmicus TherapeuticsCochlearConvaTecEndologixNational Institute on Deafness and Other Communication Disorders (NIDCD)NICHD Pelvic Floor Disorders Network
Sanford Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Sanford Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 34 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this Sanford Health page

34 registered trials is a research-attention snapshot, not an endorsement of Sanford Health or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Sanford Health pipeline card: 34 registered trials from official public datasets.Report a data error.